Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment
-
* Corresponding author: Heiner Appel heiner.appel@charite.de
Arthritis Research & Therapy 2008, 10:R125 doi:10.1186/ar2537
See related editorial by Maksymowych, http://arthritis-research.com/content/11/1/101
Accesses
- Last 30 days: 69 accesses
- Last 365 days: 638 accesses
- All time: 3220 accesses